“…Progesterone induces both genomic and non-genomic effects (Singh et al, 2013;Stanczyk et al, 2013;Schumacher et al, 2014) by the activation of nuclear (PGR) or membrane (mPR) receptors (Brinton et al, 2008;Figure 4); it has been shown that both receptors have a role in the modulation of chemoreflex response and respiratory control particularly during sleep (Bairam et al, 2019, and references therein). The exact molecular mechanism underlying this pharmacological effect is unknown; recently, in vitro studies showed that PHOX2B and desogestrel are molecularly linked demonstrating that the biologically active metabolite of desogestrel, 3-Ketodesogestrel (3-KDG; etonogestrel, ETO), modulates both wild type and mutant PHOX2B and the expression of its target genes via progesterone nuclear receptor PR-B (PGR) (Cardani et al, 2018). Remarkably, the expression of both wild-type and mutated PHOX2B is negatively regulated by 3-KDG (Figure 4).…”